MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Cerebral cavernous malformations and movement disorders

M. Polemikos, E. Hermann, J. Krauss (Hannover, Germany)

Meeting: 2019 International Congress

Abstract Number: 739

Keywords: Basal ganglia, Dystonia: Etiology and Pathogenesis, Tremors: Etiology and Pathogenesis

Session Information

Date: Monday, September 23, 2019

Session Title: Other

Session Time: 1:45pm-3:15pm

Location: Agora 2 West, Level 2

Objective: To present the unusual occurrence of movement disorders (MD) secondary to cerebral cavernous malformations (CCM).

Background: CCM most frequently become manifest by seizures, focal neurologic deficits and headaches. MDs secondary to CCM have only been rarely described in thalamic, basal ganglia and brainstem CCM. Owing to their rarity, the natural history and optimal treatment of associated MDs remains unclear.

Method: In this study we included all patients with MD associated to a CCM that presented in our department over a period of 10 years.

Results: We encountered a total of 6 patients (5 women and 1 man). Mean age was 38,5 years (range: 16-77 years). In all cases radiographic signs of previous haemorrhage was evident. MDs included following with CCMs in various locations: hemiparkinsonism – anterolateral pontomesencephalon (1); chorea – subthalamic region (1); tremor – subthalamic region/dentothalamic pathways (2); dystonia – putamen/thalamomesencephalic region (2). Two patients underwent surgical removal of the CCM with subsequent resolution of MDs. One patient had radiosurgery with disappearance of tremor but occurrence of spasticity. In three patients with moderate severity of MDs a wait-and-see strategy was adopted.

Conclusion: Treatment of MDs secondary to CCM is challenging because of their location. The optimal strategy can be chosen only on an individual basis. Location of the CCM, bleeding history, symptom severity and duration are factors that should be considered. Surgery remains a primary therapeutic option possibly providing cure in experienced neurosurgical centers. Stereotactic radiosurgery can be used in deep-seated or surgically inaccessible CCM.

References: Ghaemi K, Krauss JK, Nakamura M. Hemiparkinsonism due to a pontomesencephalic cavernoma: improvement after resection. Case report. J Neurosurg Pediatr. 2009;4(2):143-6.

To cite this abstract in AMA style:

M. Polemikos, E. Hermann, J. Krauss. Cerebral cavernous malformations and movement disorders [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/cerebral-cavernous-malformations-and-movement-disorders/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/cerebral-cavernous-malformations-and-movement-disorders/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley